| __timestamp | Agios Pharmaceuticals, Inc. | Viridian Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 293000 |
| Thursday, January 1, 2015 | 141827000 | 1002000 |
| Friday, January 1, 2016 | 220163000 | 888000 |
| Sunday, January 1, 2017 | 292681000 | 19623000 |
| Monday, January 1, 2018 | 341324000 | 30421000 |
| Tuesday, January 1, 2019 | 410894000 | 34794000 |
| Wednesday, January 1, 2020 | 367470000 | 28304000 |
| Friday, January 1, 2021 | 256973000 | 56886000 |
| Saturday, January 1, 2022 | 279910000 | 100894000 |
| Sunday, January 1, 2023 | 288903000 | 159765000 |
| Monday, January 1, 2024 | 301286000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, innovation is key to staying ahead. Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. have shown distinct approaches to research and development (R&D) spending over the past decade. From 2014 to 2023, Agios consistently invested heavily in R&D, peaking in 2019 with a 41% increase from 2014. In contrast, Viridian's R&D spending surged dramatically, especially from 2021 to 2023, where it increased by over 180%, reflecting a strategic pivot towards innovation. This trend highlights Agios's steady commitment to innovation, while Viridian's recent aggressive investment suggests a newfound focus on research. As the pharmaceutical landscape continues to shift, these companies' R&D strategies will be crucial in determining their future success and impact on healthcare advancements.
Eli Lilly and Company vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
AbbVie Inc. vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Novartis AG vs Viridian Therapeutics, Inc.: Strategic Focus on R&D Spending
Bio-Techne Corporation or Viridian Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Ascendis Pharma A/S and Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Corcept Therapeutics Incorporated and Viridian Therapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Geron Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.